Astaxanthin compositions (I)
    2.
    发明专利

    公开(公告)号:AU2016232096A1

    公开(公告)日:2017-10-05

    申请号:AU2016232096

    申请日:2016-03-18

    Applicant: BASF SE

    Abstract: The invention relates to astaxanthin compositions for use in foods, food supplements or animal feed or as a medicament. Astaxanthin compositions, which contain at least 50 wt.%, in particular at least 60 wt.%, more particularly at least 70 wt.%, especially at least 80 wt.% or at least 90 wt.%, relative to the total weight of astaxanthin and astaxanthin derivatives in the composition, a monoester of the astaxanthin having an aliphatic, unbranched C

    Astaxanthin compositions (IV)
    3.
    发明专利

    公开(公告)号:AU2016232099B2

    公开(公告)日:2020-01-16

    申请号:AU2016232099

    申请日:2016-03-18

    Applicant: BASF SE

    Abstract: The invention relates to astaxanthin compositions for use in foods, food supplements or animal feed or as a medicament. (Formula (A)) Astaxanthin compositions, which contain at least 50 wt.%, in particular at least 60 wt.%, more particularly at least 70 wt.%, and especially at least 80 wt.% or at least 90 wt.%, relative to the total weight of astaxanthin and astaxanthin derivatives in the composition, a monoester of the astaxanthin having C18-1 - fatty acid, have a particularly high bioavailability. They are therefore particularly suitable for use in foods, food supplements or animal feed and for therapeutic use as a medicament and as an ingredient for medical preparations or pharmaceutical agents.

    Astaxanthin compositions (IV)
    4.
    发明专利

    公开(公告)号:AU2016232099A1

    公开(公告)日:2017-10-12

    申请号:AU2016232099

    申请日:2016-03-18

    Applicant: BASF SE

    Abstract: The invention relates to astaxanthin compositions for use in foods, food supplements or animal feed or as a medicament. (Formula (A)) Astaxanthin compositions, which contain at least 50 wt.%, in particular at least 60 wt.%, more particularly at least 70 wt.%, and especially at least 80 wt.% or at least 90 wt.%, relative to the total weight of astaxanthin and astaxanthin derivatives in the composition, a monoester of the astaxanthin having C18-1 - fatty acid, have a particularly high bioavailability. They are therefore particularly suitable for use in foods, food supplements or animal feed and for therapeutic use as a medicament and as an ingredient for medical preparations or pharmaceutical agents.

Patent Agency Ranking